Table 2.
PGV | Total (n = 34) | |
---|---|---|
High penetrance | BRCA1 | 2 (5.9%) |
BRCA2 | 2 (5.9%) | |
CDKN2A | 1 (2.9%) | |
MLH1 | 2 (5.9%) | |
MSH6 | 1 (2.9%) | |
TP53 | 2 (5.9%) | |
Moderate penetrance | ATM | 3 (8.8%) |
CHEK2 | 1 (2.9%) | |
HOXB13 | 2 (5.9%) | |
MITF | 1 (2.9%) | |
NBN | 4 (11.8%) | |
RAD51C | 1 (2.9%) | |
RAD51D | 1 (2.9%) | |
Low penetrance | BARD1 | 1 (2.9%) |
MUTYH (monoallelic) | 6 (17.6%) | |
RAD50 | 1 (2.9%) | |
Recessive alleles | BLM (monoallelic) | 1 (2.9%) |
RECQL4 | 1 (2.9%) | |
WRN | 1 (2.9%) |